Free cookie consent management tool by TermsFeed

Our Portfolio

Home > Our Portfolio 

Sandstone Dx
Series A
Preferred Equity
01/2014

Sandstone Dx

Sandstone aims to disrupt the $44B clinical diagnostics industry by providing connected wellness products that allow consumers to measure, monitor, and improve key health markers at home. Our lead product, Trak, is a consumer male fertility test kit and mobile app that allows couples to monitor and improve sperm quality from the comfort and privacy of home.

Sandstone Diagnostics offers a centrifuge system that provides plasma and serum collection at-home and the point-of-care. It specializes in the fields of clinical diagnostics, home healthcare, and fertility. It was founded in 2012 and headquartered in Pleasanton, California.

The intellectual property attributed to Sandstone Diagnostics was acquired by Laboratory Corporation of America in 2021 yielding no return on investment to prior investors.